The FDA made two de­ci­sions on Re­gen­eron’s best-sell­ing drugs Fri­day, hand­ing down one ap­proval and one re­jec­tion.

The UK on Thursday authorized GSK’s Blenrep to treat certain multiple myeloma patients in two different regimens, marking the ...

Under the 11-page 'roadmap' outlined Thursday, the goal is for animal testing to become 'the exception rather than the norm' ...

A hot antibody discovery team in China has signed its second US biotech deal in less than six months, marking the latest sign ...

Sanofi is teaming up with a private biotech in Delaware on a pair of bispecific antibodies for autoimmune and inflammatory ...

Jacob Elkins has left Sarepta to take the CMO job at AIRNA, the RNA editing shop that disclosed a $155 million Series ...

Port Therapeutics and other early biotech startups face funding challenges as investors prefer clinical-stage companies, with ...

Trump's drug pricing EO includes wins on pill penalty reform, faster approvals, and PBM rules, but adds scrutiny on pricing ...

UnitedHealth Group reported disappointing first-quarter earnings and cut its financial guidance, hit by high costs in its ...

The 340B drug discount program may move under the purview of CMS, according to a leaked HHS restructuring document reviewed ...

The Dutch government is committing €1.3 billion ($1.5 billion) to support biotech as part of a broader raft of measures ...

Roche is stopping patients on the low dose of its experimental Huntington’s drug tominersen, and will be transitioning them ...